Strategies for Testing your Automation System - Three Part Blog Series

Testing your clinical automation system before you go live is always a challenge. There is no universal recipe or roadmap to guide laboratories on how to verify the operation of their automation according to their workflow and requirements. Learn how you can apply a risk-based approach to validate your automation system using a systematic methodology that takes the stress out of planning your testing program.

Read More
Anne L. Tate
Lab IT crisis: Why do paper-based manual processes still exist in the lab?

Labs that continue to maintain paper-dependent processes will struggle to keep pace with the changing COVID-19 environment. Paper and manual based processes set up unintended and unforeseen bottlenecks in the laboratory and across the organization that are detrimental to your lab and organization. Learn why paper based systems could endanger your data integrity and quality more than you think.

Read More
Anne L. TateComment
3-Part Blog Series: The Autoverification Return on Investment (ROI) Part III: The ROI calculation-breakdown and how to interpret the outcome

An effective autoverification ROI should reflect your current and future state. The final step in any ROI design is to estimate your autoverification program benefits and costs to win approval and link it to your program’s overall value. We show you how to layout your autoverification ROI in a wholistic approach to bridge the clinical with the financial to secure stakeholder approval.

Read More
3-Part Blog Series: The Autoverification Return on Investment (ROI) Part II: The Anatomy of the Autoverification ROI Calculation Inputs

The process of building an autoverification ROI that tells your story can be an intimidating task. How do you gather costs and benefits in an overwhelming sea of laboratory data? Our ROI takes a simplified approach of leveraging your current results review data to build a strong ROI business case. Explore how to breakdown your data to successfully support your autoverification solution purchase.

Read More
Anne L. TateComment
Talking Laboratories Contributes to Dark Daily White Paper

Anne Tate from Talking Laboratories contributed to a Dark Daily white paper that discusses how a laboratory can replace outreach manual order entry processes with automation. The white paper explores how laboratories can expand their revenue generation and capabilities by using automation to collect, process and report their data both horizontally and vertically to increase data use and reliability

Read More
Talking Laboratories - Our most popular blogs of 2020

Our mission this year was to introduce our blog series that would inspire you to dig deeper when thinking about IT and informatics. No doubt, 2020 was an eventful year and Talking Laboratories wanted to be a part of the conversation. We hope that our blogs have been insightful and thought provoking. Check out our most popular blogs of 2020.

Read More
Anne L. TateComment
3-Part Blog Series: The Autoverification Return on Investment (ROI) Part I: Making the Case for an Autoverification ROI

Want to justify an autoverification investment or expansion of your rules-based program? A Return on investment (ROI) is an effective and powerful tool to tell your story to justify your business needs. A ROI based on clinical and operational improvements can connect the dots to prove your program value and get the funding you need to build your ideal autoverification program

Read More
3-Part Blog Series: The Auto-Verification (AV) Return on Investment

We are rolling out a 3-part blog series on the Auto-Verification Return on Investment. Our three part blog series gives you a road map on how to prepare a AV ROI justification that is customized by laboratory discipline. Follow along our blog series as we lead you step-by-step through the process of creating a meaningful auto-verification ROI business case.

Read More
Crowdsourcing technology directs faster lab testing

Scaling up and building an adaptive network of COVID-19 testing requires new technologies. The use of crowdsourcing to match demand with excess laboratory capacity is emerging as a solution to coordinate the right test at the right time. Crowdsourcing technology can help bridge the healthcare divide by rapidly connecting labs with providers to improve the velocity of COVID-19 testing.

Read More
Supply chain risk assessment - Strong defense that builds resilience

Performing a supply chain risk assessment has never been more important as the world becomes more interconnected and your product dependencies become more complex. If your lab is considering multiple COVID-19 analyzer platforms or products to shore up your testing coverage, a supply chain risk assessment will identify those overlapping supply chain issues

Read More
COVID-19 supply chain risk assessments build resilience

Performing a supply chain risk assessment has never been more important, especially for COVID-19 testing kits and instrumentation. If you are considering multiple COVID-19 testing platforms to shore up your testing coverage, a new set of risk criteria should be considered to mitigate any supply chain disruptions. The rules have changed, and your risk assessment will help you build-in resilience into your supply chain.

Read More
COVID-19 reporting – When interoperability matters

The standardization of data transmission across the healthcare spectrum has never been more important or critical. Interoperability is the bridge between the medical community, our healthcare system and public health. One of the tools that can make a difference in the virus spread is data congruence to identify and manage the COVID-19 virus spread, support disease containment and influence future public policy.

Read More